Timosaponin AⅢ induces drug-metabolizing enzymes by activating constitutive androstane receptor (CAR)

CAR EGFR signaling pathway ERK1/2 signaling pathway Timosaponin AⅢ metabolism enzyme

Journal

Journal of biomedical research
ISSN: 1674-8301
Titre abrégé: J Biomed Res
Pays: China
ID NLM: 101551157

Informations de publication

Date de publication:
25 May 2024
Historique:
medline: 31 5 2024
pubmed: 31 5 2024
entrez: 31 5 2024
Statut: aheadofprint

Résumé

This study aims to assess the impact of Timosaponin AⅢ (T-AⅢ) on drug-metabolizing enzymes in anticancer treatment.

Identifiants

pubmed: 38817007
doi: 10.7555/JBR.38.20240055
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-16

Auteurs

Muhammad Zubair Hafiz (MZ)

Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Jie Pan (J)

Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Zhiwei Gao (Z)

Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Ying Huo (Y)

Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Haobin Wang (H)

Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Wei Liu (W)

Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Jian Yang (J)

Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Classifications MeSH